Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole effectiveness and cognitive function in schizophrenia
NCT00329810Phase 4Completed
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization
- Start
- Mar 2005
- Primary completion
- Mar 2006
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of aripiprazole in schizophrenia, sponsored by Otsuka Pharmaceutical Development & Commercialization. Started Mar 2005; status: completed.
02
Drugs
aripiprazole
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00329810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00329810.